{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:51:37Z","timestamp":1762865497795},"reference-count":4,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,1,29]]},"DOI":"10.1182\/blood-2008-10-182170","type":"journal-article","created":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T17:33:06Z","timestamp":1233250386000},"page":"1200-1201","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":12,"title":["Trisomy 13: prevalence and clinicopathologic correlates of another potentially lenalidomide-sensitive cytogenetic abnormality"],"prefix":"10.1182","volume":"113","author":[{"given":"Ruben A.","family":"Mesa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curtis A.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhett P.","family":"Ketterling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Schwager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan A.","family":"Knudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111721220680100_B1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa041668","article-title":"Efficacy of lenalidomide in myelodysplastic syndromes.","volume":"352","author":"List","year":"2005","journal-title":"N Engl J Med"},{"key":"2019111721220680100_B2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood-2006-02-004572","article-title":"Lenalidomide therapy in myelofibrosis with myeloid metaplasia.","volume":"108","author":"Tefferi","year":"2006","journal-title":"Blood"},{"key":"2019111721220680100_B3","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/sj.leu.2404398","article-title":"Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2(V617F) positive, del(5)(q13q33) myelodysplastic syndrome.","volume":"20","author":"Mesa","year":"2006","journal-title":"Leukemia"},{"key":"2019111721220680100_B4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1182\/blood-2008-04-152678","article-title":"Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13.","volume":"113","author":"Fehniger","year":"2009","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/5\/1200\/1309401\/zh800509001200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/113\/5\/1200\/1309401\/zh800509001200.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T02:22:12Z","timestamp":1574043732000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/113\/5\/1200\/25674\/Trisomy-13-prevalence-and-clinicopathologic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,29]]},"references-count":4,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,1,29]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-10-182170","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,29]]}}}